D-189-2013 Class II Terminated

Recalled by West-Ward Pharmaceutical Corp. — Eatontown, NJ

FDA drug recall D-189-2013 was initiated by West-Ward Pharmaceutical Corp. on Nov 30, 2012 and is designated Class II. Reason for recall: Discoloration: Ethambutol Tablets USP 400 mg have tablets cores that may be discolored. The recall status is terminated (terminated Jan 14, 2014). Affected quantity: 18,825 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 13, 2013
Initiation Date
Nov 30, 2012
Termination Date
Jan 14, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
18,825 bottles

Product description

VERSAPHARM Ethambutol Tablets, USP,400 mg, Rx Only a)60 tablets, NDC 61748-014-06, b)90 tablets, NDC 61748-014-09, c)100 tablets, NDC 61748-014-01, d)1000 tablets, NDC 61748-014-10, e) blister pack (10s) 61748-014-11 Manufactured for: VersaPharm Incorporated Marietta, GA 30062-2260, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ 07724.

Reason for recall

Discoloration: Ethambutol Tablets USP 400 mg have tablets cores that may be discolored.

Distribution pattern

GA

Code information

68977A; 68977B; 68978B; 68978C; 68979A - exp JUL 2015 68977C; 68978A exp JUL 2013

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-189-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-189-2013. Report a data issue: hello@regdatalab.com.